Search
for
Sort by
Research 571–600 of 1000+
- Polycystic Ovary Syndrome
- Ritlecitinib: First Approval
- Management of Hair Loss
- Folliculitis decalvans: a multicentre review of 82 patients
- Oestrogen functions in skin and skin appendages
- Prostate Cancer Early Detection, Version 2.2015
- Dermatology of androgen-related disorders
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Oral isotretinoin for acne
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Drug-induced acne
- Compliance With Contraceptives and Other Treatments
- Vitamin D Receptor, UVR, and Skin Cancer: A Potential Protective Mechanism
- Hormonal treatment of acne vulgaris: an update
- Combined hormonal contraception and venous thromboembolism
- The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond
- A Scarless Healing Tale: Comparing Homeostasis and Wound Healing of Oral Mucosa With Skin and Oesophagus
- Female type of adult acne: Physiological and psychological considerations and management
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Side effects of common acne treatments
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Topical delivery of nanoemulsions for skin cancer treatment
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Finasteride-its impact on sexual function and prostate cancer
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- 5α-Reductase inhibitors in androgenetic alopecia
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?